Welcome to our dedicated page for Synchrony Financial SEC filings (Ticker: SYF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Synchrony Financial (NYSE: SYF) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its consumer financing and consumer financial services business. This SEC filings page organizes those disclosures so investors can review how Synchrony reports on its credit performance, capital structure, governance and financial results.
Recent Form 8-K filings show that Synchrony regularly furnishes monthly charge-off and delinquency statistics for its portfolio, covering thirteen-month periods as of specific month-ends. These Regulation FD disclosures give investors a view into credit quality trends and are furnished rather than filed for certain liability purposes. Other 8-Ks report quarterly earnings releases, accompanied by financial data supplements, financial results presentations and explanations of non-GAAP measures, which together outline the company’s operating performance and key metrics.
Synchrony also uses Form 8-K to describe capital markets and capital return actions. One filing details an underwriting agreement for the public offering of fixed-to-floating rate senior notes due 2029 and 2036 under an effective shelf registration statement, including references to the governing indenture and related legal opinions. Additional filings and press releases discuss board-approved share repurchase authorizations and quarterly cash dividends on common and preferred stock series.
Corporate governance disclosures appear in filings covering the election of directors, committee assignments, director compensation and outcomes of the annual meeting of stockholders, including votes on director elections, auditor ratification and advisory votes on executive compensation. Through Stock Titan, users can access these filings as they are made available on EDGAR, while AI-powered summaries help explain the structure and implications of key documents such as 8-Ks, annual and quarterly reports and other material disclosures related to SYF.
Synchrony Financial reported an equity award to one of its directors. On December 31, 2025, the director acquired 660 shares of Synchrony Financial common stock in the form of restricted stock units at a reference price of $83.43 per share. After this transaction, the director beneficially owns 3,972 shares of common stock directly.
The 660 restricted stock units will vest in full on December 31, 2026, and each unit represents a contingent right to receive one share of Synchrony Financial common stock. This filing reflects a routine director equity grant rather than an open-market stock purchase or sale.
Synchrony Financial director reported receiving a grant of restricted stock units. On December 31, 2025, the director acquired 660 shares of Synchrony Financial common stock in the form of restricted stock units at a reference price of $83.43 per share. Following this transaction, the director beneficially owns 660 shares directly. The filing notes that these restricted stock units will vest in full on December 31, 2026, and each unit represents a contingent right to receive one share of common stock.
Synchrony Financial director reports new stock award. A company director filed details of a stock-based compensation grant involving Synchrony Financial common stock. On 12/31/2025, the director acquired 660 shares in the form of restricted stock units at a value of $83.43 per share. After this grant, the director beneficially owns 16,218 shares of Synchrony Financial common stock in direct ownership.
The filing notes that these 660 restricted stock units will vest in full on December 31, 2026, and each unit represents a contingent right to receive one share of Synchrony Financial common stock.
Synchrony Financial director reports stock grant
A director of Synchrony Financial reported acquiring 660 shares of common stock on December 31, 2025 at a price of $83.43 per share, as shown in a Form 4 filing. Following this transaction, the director beneficially owns 50,411 shares of Synchrony Financial common stock in direct ownership.
The filing explains that this grant represents restricted stock units that will vest in full on December 31, 2026, with each unit converting into one share of Synchrony Financial common stock at vesting. This reflects routine equity-based compensation rather than an open-market purchase or sale.
Synchrony Financial director reports stock-based award and holdings
A Synchrony Financial director reported receiving 660 shares of common stock as a stock-based award on 12/31/2025 at a price of $83.43 per share. These are in the form of restricted stock units that will vest in full on December 31, 2026, with each unit representing a contingent right to receive one share of Synchrony Financial common stock.
Following this grant, the director beneficially owns 38,734 shares directly and 34,106 shares indirectly through Guthrie 2012 Investments LP, where he is the investment manager and disclaims beneficial ownership except for his direct pecuniary interest.
Synchrony Financial reported an equity award to one of its directors. On December 31, 2025, the director acquired 1,035 shares of Synchrony Financial common stock at a price of $83.43 per share, recorded as an acquisition of non-derivative securities. After this transaction, the director beneficially owned 62,487 shares of Synchrony Financial common stock in direct form.
The filing explains that this grant represents restricted stock units that will vest in full on December 31, 2026. Each restricted stock unit gives the director a contingent right to receive one share of Synchrony Financial common stock once the vesting date is reached, aligning director compensation with the company’s share performance.
Synchrony Financial director reports stock-based compensation grant. A board member of Synchrony Financial received 660 shares of common stock on December 31, 2025 at a price of $83.43 per share, reported as an acquisition of non-derivative securities. Following this transaction, the director beneficially owns 36,444 shares of Synchrony Financial common stock in direct ownership.
The grant represents restricted stock units that will vest in full on December 31, 2026, with each unit convertible into one share of Synchrony Financial common stock. This filing reflects routine equity compensation for a director rather than an open-market purchase or sale.
Synchrony Financial reported that one of its directors acquired additional equity through a stock-based award. On December 31, 2025, the director received 660 shares of common stock, shown at a price of $83.43 per share, bringing the director’s directly held beneficial ownership to 30,529 shares after the transaction.
An explanation clarifies that this award represents restricted stock units that will vest in full on December 31, 2026, with each unit converting into one share of Synchrony Financial common stock when vested. This filing reflects routine director compensation in the form of equity rather than an open-market purchase or sale.
Synchrony Financial filed a current report announcing that it is providing investors with updated credit quality information. The company is furnishing, as Exhibit 99.1, its Monthly Charge-Off and Delinquency Statistics for each of the thirteen months ended November 30, 2025, giving a view of recent trends in loan performance and customer payment behavior.
Synchrony states that it plans to continue furnishing these statistics every month. For the final month of each calendar quarter, the data will be released at the same time as the company’s quarterly financial results, helping readers see how credit metrics and overall performance align. The company also clarifies that this information is being “furnished” under a disclosure item rather than “filed,” which affects how it is treated under securities law.
Synchrony Financial (SYF) reported an insider equity accrual for its EVP and CFO on a Form 4. On 11/17/2025, the officer received 294 dividend equivalent units tied to restricted stock units, reflecting dividends paid on the underlying common shares at a reference price of $70.47 per unit. These dividend equivalent units vest and settle on the same schedule and terms as the related restricted stock units, and each unit is economically equal to one share of Synchrony Financial common stock.
After this transaction, the reporting person beneficially owned 69,170 common shares or related units on a direct basis.